Three Changes to Pharmaceutical Patents in the PRC

Published date13 May 2021
Subject MatterPatents,China,Intellectual Property Litigation,Patent Litigation,Pharmaceutical Patents,Patent Examinations,Patent Infringement,PRC,Pharmaceutical Industry
AuthorYingli Wang, PH.D.,Jian Wen,Aolei Li
Law FirmPerkins Coie

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT